$GME
GameStop Corp.

2023 Q2 Form 10-Q Financial Statement

#000132638023000028 Filed on June 07, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2022 Q2
Revenue $1.237B $1.378B
YoY Change -10.25% 7.96%
Cost Of Revenue $949.8M $1.080B
YoY Change -12.05% 14.07%
Gross Profit $287.3M $298.5M
YoY Change -3.75% -9.57%
Gross Profit Margin 23.22% 21.66%
Selling, General & Admin $345.7M $452.2M
YoY Change -23.55% 22.12%
% of Gross Profit 120.33% 151.49%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $13.70M $17.10M
YoY Change -19.88% -8.56%
% of Gross Profit 4.77% 5.73%
Operating Expenses $345.7M $452.2M
YoY Change -23.55% 22.12%
Operating Profit -$58.40M -$153.7M
YoY Change -62.0% 276.72%
Interest Expense $9.700M $700.0K
YoY Change 1285.71% -97.17%
% of Operating Profit
Other Income/Expense, Net -$1.900M $0.00
YoY Change
Pretax Income -$50.60M -$154.4M
YoY Change -67.23% 135.73%
Income Tax -$100.0K $3.500M
% Of Pretax Income
Net Earnings -$50.50M -$157.9M
YoY Change -68.02% 136.38%
Net Earnings / Revenue -4.08% -11.46%
Basic Earnings Per Share -$0.17 -$2.08
Diluted Earnings Per Share -$0.17 -$2.08
COMMON SHARES
Basic Shares Outstanding 304.5M shares 75.90M shares
Diluted Shares Outstanding 304.5M shares 75.90M shares

Balance Sheet

Concept 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.310B $1.035B
YoY Change 26.58% 48.99%
Cash & Equivalents $1.057B $1.035B
Short-Term Investments $253.1M
Other Short-Term Assets $65.80M $105.0M
YoY Change -37.33% -20.27%
Inventory $759.5M $917.6M
Prepaid Expenses $65.80M $240.3M
Receivables $119.2M $103.4M
Other Receivables $0.00 $168.6M
Total Short-Term Assets $2.255B $2.330B
YoY Change -3.22% 40.57%
LONG-TERM ASSETS
Property, Plant & Equipment $123.6M $157.4M
YoY Change -21.47% -18.28%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $78.70M $37.80M
YoY Change 108.2% -5.5%
Total Long-Term Assets $815.6M $795.9M
YoY Change 2.48% -12.1%
TOTAL ASSETS
Total Short-Term Assets $2.255B $2.330B
Total Long-Term Assets $815.6M $795.9M
Total Assets $3.070B $3.126B
YoY Change -1.77% 21.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $561.4M $386.8M
YoY Change 45.14% -0.46%
Accrued Expenses $546.4M $533.3M
YoY Change 2.46% -5.07%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $10.90M $6.500M
YoY Change 67.69% -86.49%
Total Short-Term Liabilities $1.320B $1.127B
YoY Change 17.09% -7.47%
LONG-TERM LIABILITIES
Long-Term Debt $26.30M $35.70M
YoY Change -26.33%
Other Long-Term Liabilities $40.30M $137.7M
YoY Change -70.73% 578.33%
Total Long-Term Liabilities $40.30M $137.7M
YoY Change -70.73% 578.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.320B $1.127B
Total Long-Term Liabilities $40.30M $137.7M
Total Liabilities $1.799B $1.675B
YoY Change 7.39% -0.5%
SHAREHOLDERS EQUITY
Retained Earnings -$270.0M -$64.30M
YoY Change 319.91% -115.76%
Common Stock $1.622B $1.588B
YoY Change 2.14% 206.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.272B $1.451B
YoY Change
Total Liabilities & Shareholders Equity $3.070B $3.126B
YoY Change -1.77% 21.96%

Cashflow Statement

Concept 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$50.50M -$157.9M
YoY Change -68.02% 136.38%
Depreciation, Depletion And Amortization $13.70M $17.10M
YoY Change -19.88% -8.56%
Cash From Operating Activities -$102.7M -$303.9M
YoY Change -66.21% 1516.49%
INVESTING ACTIVITIES
Capital Expenditures $9.100M $10.80M
YoY Change -15.74% -26.53%
Acquisitions
YoY Change
Other Investing Activities $100.0K $76.90M
YoY Change -99.87%
Cash From Investing Activities -$6.700M $66.10M
YoY Change -110.14% -549.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net $0.00
YoY Change -100.0%
Cash From Financing Activities -$2.800M -$1.100M
YoY Change 154.55% -100.65%
NET CHANGE
Cash From Operating Activities -$102.7M -$303.9M
Cash From Investing Activities -$6.700M $66.10M
Cash From Financing Activities -$2.800M -$1.100M
Net Change In Cash -$116.2M -$236.3M
YoY Change -50.83% -274.01%
FREE CASH FLOW
Cash From Operating Activities -$102.7M -$303.9M
Capital Expenditures $9.100M $10.80M
Free Cash Flow -$111.8M -$314.7M
YoY Change -64.47% 839.4%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 dei Amendment Flag
AmendmentFlag
false
CY2023Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001326380
CY2023Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--02-03
CY2023Q2 dei Document Type
DocumentType
10-Q
CY2023Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q2 dei Document Period End Date
DocumentPeriodEndDate
2023-04-29
CY2023Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q2 dei Entity File Number
EntityFileNumber
1-32637
CY2023Q2 dei Entity Registrant Name
EntityRegistrantName
GameStop Corp.
CY2023Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-2733559
CY2023Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
625 Westport Parkway
CY2023Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
76051
CY2023Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Grapevine,
CY2023Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023Q2 dei City Area Code
CityAreaCode
(817)
CY2023Q2 dei Local Phone Number
LocalPhoneNumber
424-2000
CY2023Q2 dei Security12b Title
Security12bTitle
Class A Common Stock
CY2023Q2 dei Trading Symbol
TradingSymbol
GME
CY2023Q2 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q2 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q2 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
304751243 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1057000000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1035000000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1139000000 usd
CY2023Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
253100000 usd
CY2022Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
0 usd
CY2023Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
251600000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2200000 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3500000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2200000 usd
CY2023Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
119200000 usd
CY2022Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
103400000 usd
CY2023Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
153900000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
759500000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
917600000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
682900000 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
65800000 usd
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
273600000 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
96300000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
2254600000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
2329600000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
2323700000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
988300000 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
993600000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1006800000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
123600000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
157400000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
136500000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
595800000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
568700000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
560800000 usd
CY2023Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
17500000 usd
CY2022Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
16700000 usd
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
18300000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
78700000 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
53100000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
74100000 usd
CY2023Q2 us-gaap Assets
Assets
3070200000 usd
CY2022Q2 us-gaap Assets
Assets
3125500000 usd
CY2023Q1 us-gaap Assets
Assets
3113400000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
561400000 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
386800000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
531300000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
546400000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
533300000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
602300000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
200800000 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
200300000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
194700000 usd
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
10900000 usd
CY2022Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
6500000 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
10800000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1319500000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1126900000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1339100000 usd
CY2023Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
26300000 usd
CY2022Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
35700000 usd
CY2023Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
28700000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
412500000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
374500000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
382400000 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
40300000 usd
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
137700000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
40900000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
1798600000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
1674800000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
1791100000 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
304700000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
304700000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
303600000 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
303600000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
304600000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
304600000 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
100000 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
100000 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
100000 usd
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1621400000 usd
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1587500000 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1613600000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-79900000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-72600000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-71900000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-270000000.0 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-64300000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-219500000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1271600000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1450700000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1322300000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3070200000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3125500000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3113400000 usd
CY2023Q2 us-gaap Revenues
Revenues
1237100000 usd
CY2022Q2 us-gaap Revenues
Revenues
1378400000 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
949800000 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
1079900000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
287300000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
298500000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
345700000 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
452200000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-58400000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-153700000 usd
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
9700000 usd
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-700000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1900000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-50600000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-154400000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-100000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3500000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-50500000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-157900000 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.52
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.52
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
304500000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
303600000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
304500000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
303600000 shares
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-50500000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-157900000 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-8100000 usd
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-3900000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
1200000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
0 usd
CY2023Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
400000 usd
CY2022Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
0 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-900000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-58500000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-161800000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-50500000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-157900000 usd
CY2023Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
13700000 usd
CY2022Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
17100000 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
7900000 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
11100000 usd
CY2023Q2 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
0 usd
CY2022Q2 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
33700000 usd
CY2023Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-600000 usd
CY2022Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-400000 usd
CY2023Q2 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
200000 usd
CY2022Q2 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-4800000 usd
CY2023Q2 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-35600000 usd
CY2022Q2 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-36300000 usd
CY2023Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
83100000 usd
CY2022Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9900000 usd
CY2023Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4000000.0 usd
CY2022Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
30300000 usd
CY2023Q2 gme Prepaid Income Taxes And Accrued Income Taxes Payable
PrepaidIncomeTaxesAndAccruedIncomeTaxesPayable
200000 usd
CY2022Q2 gme Prepaid Income Taxes And Accrued Income Taxes Payable
PrepaidIncomeTaxesAndAccruedIncomeTaxesPayable
-3500000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-22300000 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-179800000 usd
CY2023Q2 gme Increase Decrease In Right Of Use Assets And Lease Liabilities
IncreaseDecreaseInRightOfUseAssetsAndLeaseLiabilities
600000 usd
CY2022Q2 gme Increase Decrease In Right Of Use Assets And Lease Liabilities
IncreaseDecreaseInRightOfUseAssetsAndLeaseLiabilities
16400000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-102700000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-303900000 usd
CY2023Q2 us-gaap Proceeds From Sale Of Other Assets Investing Activities
ProceedsFromSaleOfOtherAssetsInvestingActivities
1300000 usd
CY2022Q2 us-gaap Proceeds From Sale Of Other Assets Investing Activities
ProceedsFromSaleOfOtherAssetsInvestingActivities
76900000 usd
CY2023Q2 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
211000000.0 usd
CY2022Q2 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
0 usd
CY2023Q2 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
212200000 usd
CY2022Q2 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0 usd
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9100000 usd
CY2022Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10800000 usd
CY2023Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
100000 usd
CY2022Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6700000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
66100000 usd
CY2023Q2 gme Settlement Of Stock Based Awards
SettlementOfStockBasedAwards
100000 usd
CY2022Q2 gme Settlement Of Stock Based Awards
SettlementOfStockBasedAwards
1100000 usd
CY2023Q2 us-gaap Repayments Of Debt
RepaymentsOfDebt
2700000 usd
CY2022Q2 us-gaap Repayments Of Debt
RepaymentsOfDebt
0 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2800000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1100000 usd
CY2023Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-4000000.0 usd
CY2022Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2600000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-116200000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-236300000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1196000000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1319900000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1079800000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1083600000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1322300000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-50500000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8100000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
1200000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7900000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-100000 usd
CY2023Q2 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
-400000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-900000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1271600000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1602500000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-157900000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3900000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11100000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-1100000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1450700000 usd
CY2023Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4 segment
CY2023Q2 us-gaap Fiscal Period
FiscalPeriod
The accompanying condensed consolidated financial statements and notes are unaudited. The consolidated financial statements should be read in conjunction with our Annual Report on Form 10-K for the 52 weeks ended January 28, 2023 ("fiscal 2022"), as filed with the Securities and Exchange Commission ("SEC") on March 28, 2023 (the “2022 Annual Report on Form 10-K”). Due to the seasonal nature of our business, our results of operations for the three months ended April 29, 2023 are not indicative of our future results for the 53 weeks ending February 3, 2024 ("fiscal 2023"). Our fiscal year is composed of the 52 or 53 weeks ending on the Saturday closest to the last day of January. Fiscal 2023 consists of 53 weeks ending on February 3, 2024. Fiscal 2022 consisted of 52 weeks ended on January 28, 2023. All three month periods presented herein contain 13 weeks. All references to years, quarters and months relate to fiscal periods rather than calendar periods. Our business, like that of many retailers, is seasonal, with the major portion of the net sales realized during the fourth quarter, which includes the holiday selling season.
CY2023Q2 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain amounts presented in our prior period financial statements have been reclassified to conform to the presentation of the current period financial statements.</span></div>
CY2022Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
4
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Use</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">of</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Estimates</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying footnotes. We regularly evaluate the estimates related to our assets and liabilities, contingent assets and liabilities, and the reported amounts of revenues and expenses. In preparing these condensed consolidated financial statements, we have made our best estimates and judgments of certain amounts recognized in the condensed consolidated financial statements, giving due consideration to materiality. Changes in the estimates and assumptions that we have used could have a significant impact on our financial results. Actual results could differ from those estimates.</span></div>
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1057000000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1035000000 usd
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
7500000 usd
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
33300000 usd
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
15300000 usd
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
15300000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1079800000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1083600000 usd
CY2022Q2 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
7200000 usd
CY2023Q2 us-gaap Revenues
Revenues
1237100000 usd
CY2022Q2 us-gaap Revenues
Revenues
1378400000 usd
CY2023Q2 us-gaap Deferred Credits And Other Liabilities Current
DeferredCreditsAndOtherLiabilitiesCurrent
325500000 usd
CY2022Q2 us-gaap Deferred Credits And Other Liabilities Current
DeferredCreditsAndOtherLiabilitiesCurrent
330000000.0 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
338200000 usd
CY2022Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
378300000 usd
CY2023Q2 gme Increase To Contract Liabilities
IncreaseToContractLiabilities
169600000 usd
CY2022Q2 gme Increase To Contract Liabilities
IncreaseToContractLiabilities
207000000.0 usd
CY2023Q2 gme Decrease To Contract Liabilities
DecreaseToContractLiabilities
181300000 usd
CY2022Q2 gme Decrease To Contract Liabilities
DecreaseToContractLiabilities
253500000 usd
CY2023Q2 gme Contract With Customer Liability Increase Decrease From Other Adjustments
ContractWithCustomerLiabilityIncreaseDecreaseFromOtherAdjustments
-1000000.0 usd
CY2022Q2 gme Contract With Customer Liability Increase Decrease From Other Adjustments
ContractWithCustomerLiabilityIncreaseDecreaseFromOtherAdjustments
-1800000 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
325500000 usd
CY2022Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
330000000.0 usd
CY2022Q2 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
33700000 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
37200000 usd
CY2022Q2 us-gaap Long Term Debt
LongTermDebt
42200000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
39500000 usd
CY2023Q2 us-gaap Debt Current
DebtCurrent
10900000 usd
CY2022Q2 us-gaap Debt Current
DebtCurrent
6500000 usd
CY2023Q1 us-gaap Debt Current
DebtCurrent
10800000 usd
CY2023Q2 gme Letters Of Credit And Bank Guarantees Outstanding Amount
LettersOfCreditAndBankGuaranteesOutstandingAmount
16000000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
304500000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
303600000 shares
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
304500000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
303600000 shares
CY2023Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4 segment
CY2023Q2 us-gaap Revenues
Revenues
1237100000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-58400000 usd
CY2022Q2 us-gaap Revenues
Revenues
1378400000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-153700000 usd
CY2023Q1 us-gaap Income Tax Receivable
IncomeTaxReceivable
171500000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-100000 usd
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.002
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3500000 usd
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.023

Files In Submission

Name View Source Status
0001326380-23-000028-index-headers.html Edgar Link pending
0001326380-23-000028-index.html Edgar Link pending
0001326380-23-000028.txt Edgar Link pending
0001326380-23-000028-xbrl.zip Edgar Link pending
ex311-fy23q1.htm Edgar Link pending
ex312-fy23q1.htm Edgar Link pending
ex321-fy23q1.htm Edgar Link pending
ex322-fy23q1.htm Edgar Link pending
gme-20230429_lab.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gme-20230429.htm Edgar Link pending
gme-20230429.xsd Edgar Link pending
gme-20230429_g1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
gme-20230429_cal.xml Edgar Link unprocessable
gme-20230429_def.xml Edgar Link unprocessable
gme-20230429_htm.xml Edgar Link completed
gme-20230429_pre.xml Edgar Link unprocessable